Dr andri iona
Contact information
Andri Iona
MSc, DPhil
Medical Statistician
Andri Iona is a medical statistician working on the China Kadoorie Biobank.
Her research interests focus on the observational and genetic associations of adiposity with cardiovascular diseases. She implements statistical analyses for publications and contributes to the development of statistical resources. She also contributes to the MSc in Global Health Science and Epidemiology programme at the University of Oxford as a lecturer and statistics tutor.
She obtained a Bachelor’s degree in Statistics and Actuarial – Financial Mathematics from the University of Aegean (in Greece), an MSc in Medical Statistics from University of Leicester and a DPhil in Population Health from the University of Oxford. Her DPhil investigated the association of adiposity and major plasma biomarkers with the risk of cardiovascular diseases and mortality in Chinese adults. Prior to commencing her DPhil, Andri worked as a medical statistician in the China Kadoorie Biobank looking at the relationships between smoking and cause-specific mortality, diabetes and cause-specific mortality, adiposity and diabetes incidence, and adiposity and stroke.
Recent publications
Young adulthood adiposity in relation to all-cause and cause-specific mortality: a prospective study of 0.5 million Chinese adults.
Journal article
Fan L. et al, (2026), Sci Bull (Beijing)
Dairy consumption and risk of cardiometabolic diseases: a prospective cohort study of the China Kadoorie Biobank.
Journal article
Kakkoura MG. et al, (2026), J Nutr
Cardiometabolic health and risk of dementia and brain atrophy: a community-based prospective cohort study of 0.5 million adults in China.
Journal article
Bueno Lopez C. et al, (2025), Lancet Reg Health West Pac, 64
Associations of 2923 Olink proteins with demographic, lifestyle, environmental and health characteristics in middle-aged Chinese adults.
Journal article
Iona A. et al, (2025), Eur J Epidemiol, 40, 1205 - 1220
Proteome-Wide Genetic Study in East Asians and Europeans Identified Multiple Therapeutic Targets for Ischemic Stroke.
Journal article
Yao P. et al, (2025), Stroke, 56, 2147 - 2158
